Stephen A. Krahling and Joan A. Wlochowski, former Merck virologists blew the whistle by filing a qui tam action lawsuit — U.S. v Merck & Co. — in August 2010. The scientists allege that the efficacy tests for the measles, mumps, rubella . . . Continue reading →
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH) “Real Men, Real Depression campaign http://menanddepression.nimh.nih.gov/infopage.asp?ID=1 Continue reading →
The WSJ confirms that Merck is "desperate" for funding streams and "vaccination across the U.S. would make Gardasil an automatic blockbuster." Continue reading →
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller. Continue reading →
Repeat legal violations: The record of recidivism by major drug manufacturers is a matter of public record.
Continue reading →
Read: Transcript of Hearing Re: RE: ZYPREXA LITIGATION, MDL 04 1596 in U.S.
District Court Eastern District of NEW YORK
Continue reading →
BBC-Panorama–third in a series: The Secrets of Seroxat. "In the interests of patients and professional integrity" is to show those who have sold their reputations "intolerance and exposure." Continue reading →
The Texas whistleblower lawsuit against Johnson & Johnson promises to topple the house of cards upon which the public mental health system rests.
See: http://ahrp.blogspot.com/2007/01/big-bucks-big-pharma-documentary-video.html And see, PDUFA-Payola see: http://pharmamkting.blogspot.com/
The New York Times reports that internal marketing documents show that “Eli Lilly encouraged primary care physicians to use Zyprexa, in patients who did not have either condition.”
THE NEW YORK TIMES EXPOSE OF ELI LILLY SECRET ZYPREXA DOCUMENTS Part II.
Read Transcript of Hearing: http://ahrp.blogspot.com/2007/01/zyprexa-litigation-hearing-judge-jack.html Continue reading →